The aim of this study is to evaluate cyclosporine as a novel
therapy for dogs with insulin-resistant diabetes mellitus and
chronic pancreatitis. There is some evidence in the human
literature that chronic pancreatitis may have an underlying
immune-mediated etiology and anecdotally, cyclosporine has resulted
in improved diabetic control in a dog with chronic pancreatitis as
a cause of insulin resistance. Qualifying cases will receive
Atopica free of charge for the trial period of six weeks. For more
information please contact Dr. Heather Kvitko-White at
hkvitko-white@cvm.tamu.edu